Skip to main content
. Author manuscript; available in PMC: 2012 Aug 13.
Published in final edited form as: Liver Transpl. 2011 Oct;17(Suppl 2):S147–S158. doi: 10.1002/lt.22367

TABLE 4.

Comparison of Endpoints for Adjuvant Treatments

Events Endpoints
Disease-Free Survival Recurrence-Free Survival Overall Survival
Locoregional recurrence Event Event Ignore
Distant metastases Event Event Ignore
Second primary (same cancer) Event Ignore Ignore
Second primary (another cancer) Event Ignore Ignore
Death from the same cancer Event Event Event
Death from another cancer Event Ignore Event
Non–cancer-related death Event Ignore Event
Treatment-related death Event Ignore Event
Lost to follow-up Censor Censor Censor

NOTE: Adapted with permission from Journal of the National Cancer Institute.43 Copyright 2007, Oxford University Press.